Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.DIABRES.2004.10.005PMID 15936461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

  2009cited by this paper
• A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique

  2004cited by this paper
• Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.

  1996cited by this paper
• C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.

  1994cited by this paper
• The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes

  1992cited by this paper
• The Effect of Chronic Hyperglycaemia on the Islet B‐cell Responsiveness in Newly Diagnosed Type 2 Diabetes

  1992influential reference
• C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• C-peptide profiles in patients with non-insulin-dependent diabetes mellitus before and during insulin treatment.

  1992cited by this paper
• The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled Type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia

  1989cited by this paper
• Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group

  1987cited by this paper
• Reproducibility of βCell Function Estimates in Non-Insulin-Dependent Diabetes Mellitus

  1987cited by this paper
• Practical aspects in performing the glucagon test in the measurement of C-peptide secretion in diabetic patients.

  1986cited by this paper
• C-peptide determination in the choice of treatment in diabetes mellitus.

  1985cited by this paper
• Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon

  1977cited by this paper

• Effects of exogenous detemir and glargine insulin on the detection of endogenous C-peptide and endogenous insulin.

  2026cites this paper
• Plasma C-Peptide Levels and the Continuous Glucose Monitoring-Defined Coefficient of Variation in Risk Prediction for Hypoglycemia in Korean People with Diabetes Having Normal and Impaired Kidney Function

  2025cites this paper
• Effects of laparoscopic sleeve gastrectomy on weight loss and metabolic improvement in subjects aged 65 years or older: a subanalysis of J-SMART study

  2024cites this paper
• Factors Associated with Relapse of Type 2 Diabetes Mellitus after Laparoscopic Sleeve Gastrectomy in Japanese Subjects: A Subgroup Analysis of J-SMART Study

  2023cites this paper
• When serum c-peptide measurement drives adequate diabetes mellitus diagnosis and therapy: a case report.

  2023cites this paper
• A Cross-sectional Study to Assess Beta-Cell Function in Individuals with Recently Diagnosed Young-Onset Type 2 Diabetes Mellitus and Its’ Complications

  2022cites this paper
• Characteristics of Childhood Onset and Post-Puberty Onset Obesity and Weight Regain after Laparoscopic Sleeve Gastrectomy in Japanese Subjects: A Subgroup Analysis of J-SMART

  2022cites this paper
• Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study

  2022influential citation
• Metabolic benefits of novel histamine H3 receptor ligands in the model of excessive eating: The importance of intrinsic activity and pharmacokinetic properties.

  2021cites this paper
• Flash glucose monitoring data analysed by detrended fluctuation function on beta‐cell function and diabetes classification

  2020cites this paper
• Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus

  2020cites this paper
• Association of Glucagon With Obesity, Glycemic Control and Renal Function in Adults With Type 2 Diabetes Mellitus.

  2020cites this paper
• A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement

  2018cites this paper
• Évaluation de la fonction β cellulaire par le repas-test chez le diabétique de type 2 : intérêt clinique

  2017cites this paper
• Relation between Blood Pressure Control and Insulin Secretion Markers among Elderly Diabetic Females

  2017cites this paper
• Hypoglycaemia in older people with diabetes

  2016influential citation
• Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis

  2016cites this paper
• C-Peptide and insulin levels in patients of metabolic syndrome

  2016cites this paper
• Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

  2015cites this paper
• Markers of b-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

  2015cites this paper
• Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation.

  2015cites this paper
• Switching from insulin to liraglutide improved glycemic control and the quality of life scores in a case of type 2 diabetes and active Crohn's disease.

  2014cites this paper
• INSULIN EFFECTS ON GLUCOSE TOLERANCE , HYPERMETABOLIC RESPONSE , 1 AND CIRCADIAN-METABOLIC PROTEIN EXPRESSION IN A RAT BURN AND 2 DISUSE MODEL 3 4

  2014cites this paper
• Adding glimepiride to insulin+metformin in type 2 diabetes of more than 10 years' duration--a randomised, double-blind, placebo-controlled, cross-over study.

  2014influential citation
• Integrative and Translational Physiology : Integrative Aspects of Energy Homeostasis and Metabolic Diseases Insulin effects on glucose tolerance , hypermetabolic response , and circadian-metabolic protein expression in a rat burn and disuse model

  2014cites this paper
• Retrospective analysis of safety and efficacy of insulin‐to‐liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β‐cell function

  2013cites this paper
• The clinical utility of C-peptide measurement in the care of patients with diabetes

  2013cites this paper
• Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients

  2013cites this paper
• CLINICAL ASPECTS ON GLUCOSE-LOWERING THERAPIES IN TYPE 2 DIABETES

  2012cites this paper
• Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes

  2011cites this paper
• Decreasing postprandial C-peptide levels over time are not associated with long-term use of sulphonylurea: an observational study.

  2010cites this paper
• [Indicators for insulin therapy in late elderly patients with type 2 diabetes mellitus--the relationship between plasma C-peptide on glucagon load test and insulin therapy].

  2009cites this paper
• 2型糖尿病におけるインスリン治療の要否判定の指標としての尿中Cペプチド補正値(UCC)およびCペプチドインデックス(CPI)の有用性

  2008cites this paper
• The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus.

  2007cites this paper
• Current literature in diabetes

  2006cites this paper